AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comNOV 33 min read$WAY

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

Original reporting
finance.yahoo.com
Published Nov 3, 2026, 5:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 5:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$WAYBearishHigh
01

Why it matters

The earnings release provides fresh guidance that narrows growth expectations, likely prompting a sell‑off.

02

Market read

First report of earnings and guidance for Waystar, material for traders with exposure to health‑tech sector.

03

What to watch

Longer implementation cycles may improve future revenue visibility; AI cross‑sell potential remains underappreciated.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Waystar Holding Corp reported Q3 2026 results with 21% YoY revenue growth and announced modest Q4 guidance.

Company-level read

Ticker impact

$WAYBearishMedium confidence
Context

Q3 earnings call disclosed 21% revenue growth but Q4 guidance shows only ~6% growth and lower EBITDA margin, indicating potential downside.

Expected impact

likely downside as market prices in slower Q4 growth and reduced EBITDA margin

Evidence & confidence

Revenue growth remains strong but guidance cuts and margin decline are fresh information that can prompt sell pressure.

Market effects

Sector

AI-enabled health‑tech firms may see heightened scrutiny on guidance quality.

Regional

U.S. healthcare software sector could face modest pullback.

Global

Limited to investors tracking health‑tech earnings trends.

Counterpoint

What could challenge this read

Strong bookings and AI pipeline could support upside if implementation accelerates faster than guidance suggests.

Key entities

  • company
    Waystar Holding Corp

    U.S. health‑tech software provider.

Read at source← All news

StoryWaystar posts Q3 2026 earnings and lowers full‑year revenue outlook

Also covered by

6 outlets

Related articles

NOV 3
$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

finance.yahoo.com2 min
NOV 3
$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.

finance.yahoo.com2 min
NOV 2
$WAYHighAI 8/10

Waystar shares tumble 7% on weak fiscal 2026 guidance

Waystar Holding Corp (WAY) reported Q3 earnings of $0.44 per share, beating estimates, with revenue up 21% YoY to $325.6M. However, shares fell 7.3% on weak fiscal 2026 guidance, with projected EPS of $1.63-$1.71 and revenue of $1.277B-$1.287B, both below consensus. The company reported 10% net income margin and 43% adjusted EBITDA margin.

investing.com2 min